Health & Welfare
Vaccinating Nile tilapia against Tilapia Lake Virus (TiLV)
Immunized Nile tilapia broodstock can mount a protective antibody response to Tilapia Lake Virus and transfer antibodies to progeny.
Health & Welfare
Reproductores inmunizados de tilapia del Nilo pueden montar una respuesta de anticuerpos protectores al Virus del Lago de Tilapia y transferir anticuerpos a la progenie.
Health & Welfare
Immunized Nile tilapia broodstock can mount a protective antibody response to Tilapia Lake Virus and transfer antibodies to progeny.
Health & Welfare
Study estimates genetic parameters for host resistance to Tilapia Lake Virus in a Nile tilapia and finds TiLV resistance is highly heritable.
Health & Welfare
Este estudio evalúa la transmisión experimental del Virus de la Tilapia de Lago (TiLV) desde reproductores de tilapia a sus órganos reproductivos y óvulos fertilizados.
Health & Welfare
Study evaluates the experimental transmission of Tilapia Lake Virus (TiLV) from tilapia broodstock to their reproductive organs and fertilized eggs.
Health & Welfare
Se ha iniciado un esfuerzo internacional de investigación para encontrar una solución para el Virus del Lago de Tilapia (TiLV), un contagio que causa altas tasas de mortalidad en poblaciones de tilapia cultivada y silvestre en Israel, Colombia, Ecuador, Egipto y Tailandia.
Health & Welfare
An international research effort has commenced to find a solution for Tilapia Lake Virus (TiLV), a contagion causing high rates of mortality in farmed and wild tilapia stocks in Israel, Colombia, Ecuador, Egypt and Thailand.